Xerion Pharmaceuticals

Xerion uses their Xstream(tm) technology to identify druggable targets and therapeutic antibodies, principally for metastatic cancer and acute cardiovascular disease.

History:

Founded in 1998. Current status (10/2008) uncertain.

Employment

Email:jobs@xerion-pharma.com

Fax:N/A

Mail:
Xerion Pharmaceuticals AG
Attn: Human Resources
Fraunhoferstrasse 9
D-82152 Martinsried (Munich) Germany

General Info:

Ticker: private

Employees:

Regions:
Northeast Europe

Research Focus:
Disease

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: